These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275 [TBL] [Abstract][Full Text] [Related]
5. Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women. Mata MM; Iwema JR; Dell S; Neems L; Jamieson BD; Phair J; Cohen MH; Anastos K; Baum LL AIDS Res Hum Retroviruses; 2014 Jan; 30(1):50-7. PubMed ID: 23972002 [TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs. Tyler DS; Stanley SD; Bartlett JA; Bolognesi DP; Weinhold KJ J Surg Res; 1998 Oct; 79(2):115-20. PubMed ID: 9758725 [TBL] [Abstract][Full Text] [Related]
7. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects. Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF mBio; 2019 Dec; 10(6):. PubMed ID: 31848282 [TBL] [Abstract][Full Text] [Related]
8. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans. Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541 [TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent cell-mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1. Hildreth JE; Hampton R; Halsey NA Clin Immunol; 1999 Feb; 90(2):203-12. PubMed ID: 10080832 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive investigation of common antibody-dependent cell-mediated cytotoxicity antibody epitopes of HIV-1 CRF01_AE gp120. Ampol S; Pattanapanyasat K; Sutthent R; Permpikul P; Kantakamalakul W AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1250-8. PubMed ID: 22288892 [TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients. Jewett A; Giorgi JV; Bonavida B J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607 [TBL] [Abstract][Full Text] [Related]
13. gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease. Skowron G; Cole BF; Zheng D; Accetta G; Yen-Lieberman B AIDS; 1997 Dec; 11(15):1807-14. PubMed ID: 9412698 [TBL] [Abstract][Full Text] [Related]
14. Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. Nag P; Kim J; Sapiega V; Landay AL; Bremer JW; Mestecky J; Reichelderfer P; Kovacs A; Cohn J; Weiser B; Baum LL J Infect Dis; 2004 Dec; 190(11):1970-8. PubMed ID: 15529262 [TBL] [Abstract][Full Text] [Related]
15. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers. Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF Front Immunol; 2020; 11():583820. PubMed ID: 33101312 [TBL] [Abstract][Full Text] [Related]
16. Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease. Weinhold KJ; Tyler DS; Lyerly HK Dev Biol Stand; 1990; 72():343-8. PubMed ID: 2282991 [TBL] [Abstract][Full Text] [Related]
17. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients. Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454 [TBL] [Abstract][Full Text] [Related]
18. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients. Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370 [TBL] [Abstract][Full Text] [Related]
19. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals. Ahmad A; Morisset R; Thomas R; Menezes J J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Williams SB; Flanigan TP; Cu-Uvin S; Mayer K; Williams P; Ettore CA; Artenstein AW; Duerr A; VanCott TC Clin Infect Dis; 2002 Sep; 35(5):611-7. PubMed ID: 12173138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]